Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-23-028545

← back to feed
Filed
Aug 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q2 2023 · Jun 30, 2023 $8.34M
Current Liabilities Q2 2023 · Dec 31, 2022 $8.07M
Total Liabilities Q2 2023 · Jun 30, 2023 $8.35M
Total Liabilities Q2 2023 · Dec 31, 2022 $8.09M
Current Assets Q2 2023 · Jun 30, 2023 $3.27M
Current Assets Q2 2023 · Dec 31, 2022 $3.98M
Total Assets Q2 2023 · Jun 30, 2023 $3.84M
Total Assets Q2 2023 · Dec 31, 2022 $4.57M
Stock Issued Q2 2023 · Feb 16, 2023 2.43M sh
Stock Issued Q2 2023 · Feb 15, 2022 7.4M sh
Shares Diluted Q2 2023 · Jun 30, 2022 955.15M sh
Shares Diluted Q2 2023 · Jun 30, 2022 949.45M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$960.14K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$3.77M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$4.1M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$5.3M
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Diluted Q2 2023 · Jun 30, 2022 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Eps Basic Q2 2023 · Jun 30, 2022 $0.00
Sga Expense Q2 2023 · Jun 30, 2022 $212.42K
Sga Expense Q2 2023 · Jun 30, 2022 $425.44K
Rd Expense Q2 2023 · Jun 30, 2022 $49.87K
Rd Expense Q2 2023 · Jun 30, 2022 $77.37K
Net Income Q2 2023 · Jun 30, 2022 −$1.04M
Net Income Q2 2023 · Jun 30, 2022 −$2.08M
Operating Income Q2 2023 · Jun 30, 2022 −$536.67K
Operating Income Q2 2023 · Jun 30, 2022 −$1.08M